Minimally invasive adrenalectomy is a safe operation that cures primary hyperaldosteronism (PHA) for patients who are properly selected, at a patient outcome and morbidity cost comparable with laparoscopic cholecystectomy.1 Nevertheless, selection errors can lead to ineffective adrenalectomy in patients with bilateral causes of PHA and remove the chance for cure if the side opposite the side with the pathology is removed.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Doherty GM, Gartland RM, Duh Q. Choosing Wisely in the Workup of Primary Hyperaldosteronism. JAMA Surg. 2021;156(2):171–172. doi:10.1001/jamasurg.2020.5025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: